🇺🇸 Monovalent influenza virus vaccine in United States

6 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Aspartate Aminotransferase Increased — 1 report (16.67%)
  2. Blood Alkaline Phosphatase Increased — 1 report (16.67%)
  3. Blood Bilirubin Increased — 1 report (16.67%)
  4. Chest Pain — 1 report (16.67%)
  5. Gamma-Glutamyltransferase Increased — 1 report (16.67%)
  6. Post Vaccination Syndrome — 1 report (16.67%)

Source database →

Monovalent influenza virus vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Monovalent influenza virus vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Monovalent influenza virus vaccine in United States?

MedImmune LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.